Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Chamaecyparis obtusa, commonly known as the Hinoki or Japanese cypress, is an evergreen tree native to Japan. [11] While specific research often focuses on extracts from parts like the leaves, wood, or essential oil, the whole plant contains a complex mixture of bioactive compounds. [1, 3, 4] These components, primarily terpenes (such as α-pinene, sabinene, limonene), terpenoids (like hinokitiol), and flavonoids (including quercitrin and myricetin), are responsible for its recognized therapeutic properties. [4, 6, 7] The plant is widely known for its antimicrobial, anti-inflammatory, antioxidant, and aromatic effects. [3, 4] In traditional and modern applications, it is used in skincare for soothing irritation and acne, in aromatherapy for stress reduction, and has been investigated for a range of other potential health benefits including anticancer and antiallergic activities. [1, 3, 6]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Chamaecyparis obtusa whole.